Labcorp Holdings Inc.
LHHealthcareNASDAQDiagnostics & Research
Scan Results
Daily timeframeLabcorp Holdings Inc. provides laboratory services. The company carries a $23.24B market cap, placing it firmly in the large-cap category. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments.
Market Cap
$23.24B
Beta
0.86
P/E (TTM)
25.01
P/E (Fwd)
14.60
EPS (TTM)
$11.33
EPS (Fwd)
$19.41
ROE
11.1%
ROA
5.3%
Cash
$981.1M
Total Debt
$7.29B
Free CF
$1.14B
52W Change
16.3%
Annual Financials
Cash vs Debt
Labcorp Holdings Inc. carries $7.29B in total debt against $981.1M in cash reserves — debt is roughly 7.4x the cash position. Managing this leverage effectively will be important for long-term financial stability. Free cash flow comes in at $1.14B, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 11.1% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 5.3% suggests reasonable efficiency in deploying the company's asset base. Revenue has been uneven over recent years, ranging from $11.86B to $13.95B.
Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Labcorp Holdings Inc. and its sector.